Syntax Bio
About Syntax Bio
Syntax Bio is pioneering an approach to stem cell differentiation using a modified CRISPR system to regulate endogenous genes in a temporally controlled manner, mimicking human developmental processes at the epigenetic level.
Our Interest
Walder Ventures’ focus on science innovation is driven by Joseph Walder, M.D., Ph.D., who spent his career developing breakthrough technologies in academic research before founding a biotech company, Integrated DNA Technologies, now part of the Danaher life sciences platform, that produces synthetic DNA and RNA for life sciences research and industry.